JP2017514522A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017514522A5 JP2017514522A5 JP2017510445A JP2017510445A JP2017514522A5 JP 2017514522 A5 JP2017514522 A5 JP 2017514522A5 JP 2017510445 A JP2017510445 A JP 2017510445A JP 2017510445 A JP2017510445 A JP 2017510445A JP 2017514522 A5 JP2017514522 A5 JP 2017514522A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- modified human
- human amino
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 20
- 229920001184 polypeptide Polymers 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 8
- 210000004698 lymphocyte Anatomy 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 241000193738 Bacillus anthracis Species 0.000 claims 1
- 101001070790 Homo sapiens Platelet glycoprotein Ib alpha chain Proteins 0.000 claims 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 1
- 241000235789 Hyperoartia Species 0.000 claims 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 102000010410 Nogo Proteins Human genes 0.000 claims 1
- 108010077641 Nogo Proteins Proteins 0.000 claims 1
- 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 claims 1
- 101700004678 SLIT3 Proteins 0.000 claims 1
- 102100025490 Slit homolog 1 protein Human genes 0.000 claims 1
- 101710123186 Slit homolog 1 protein Proteins 0.000 claims 1
- 102100027340 Slit homolog 2 protein Human genes 0.000 claims 1
- 101710133576 Slit homolog 2 protein Proteins 0.000 claims 1
- 102100027339 Slit homolog 3 protein Human genes 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 229940065181 bacillus anthracis Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 210000004901 leucine-rich repeat Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000004180 plasmocyte Anatomy 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987566P | 2014-05-02 | 2014-05-02 | |
| US61/987,566 | 2014-05-02 | ||
| PCT/US2015/028645 WO2015168469A1 (en) | 2014-05-02 | 2015-04-30 | Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017514522A JP2017514522A (ja) | 2017-06-08 |
| JP2017514522A5 true JP2017514522A5 (enExample) | 2018-06-14 |
Family
ID=54359347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510445A Pending JP2017514522A (ja) | 2014-05-02 | 2015-04-30 | ヒト化可変性リンパ球受容体（ｖｌｒ）および組成物ならびにそれに関連する使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10167330B2 (enExample) |
| EP (1) | EP3137496A4 (enExample) |
| JP (1) | JP2017514522A (enExample) |
| KR (1) | KR20160147787A (enExample) |
| CN (1) | CN106459173A (enExample) |
| CA (1) | CA2947429A1 (enExample) |
| IL (1) | IL248327A0 (enExample) |
| WO (1) | WO2015168469A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2947429A1 (en) | 2014-05-02 | 2015-11-05 | Emory University | Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto |
| SE1500434A1 (en) * | 2015-10-29 | 2017-04-30 | Theravac Pharmaceuticals Ab | A novel fusion partner for highly efficient and safe vaccines |
| CN107365387B (zh) | 2016-05-12 | 2022-03-15 | 阿思科力(苏州)生物科技有限公司 | 一种双特异性抗原结合构建体及其制备方法和应用 |
| US11339225B2 (en) * | 2016-05-12 | 2022-05-24 | Asclepius (Suzhou) Technology Company Group, Co., Ltd. | Bispecific antigen-binding construct and preparation method and use thereof |
| CN106543278B (zh) * | 2016-12-06 | 2019-04-12 | 阿思科力(苏州)生物科技有限公司 | 融合蛋白Slit2D2(C386S)-HSA及其在治疗纤维化疾病中的应用 |
| WO2018140857A2 (en) * | 2017-01-27 | 2018-08-02 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Bifunctional small peptide for autoimmune diabetes |
| EP3600378A4 (en) * | 2017-03-24 | 2020-12-23 | Orpheus Bioscience Inc. | PANTIDS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS |
| SG11201909160WA (en) * | 2017-04-11 | 2019-10-30 | Inhibrx Inc | Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same |
| KR101972894B1 (ko) * | 2017-05-18 | 2019-04-29 | 경상대학교산학협력단 | 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도 |
| WO2019200022A1 (en) | 2018-04-11 | 2019-10-17 | Inhibrx, Inc. | Multispecific polypeptide constructs having constrained cd3 binding and related methods and uses |
| TW202035451A (zh) | 2018-07-24 | 2020-10-01 | 美商英伊布里克斯公司 | 含有受限cd3結合域及受體結合區之多重特異性多肽構築體及其使用方法 |
| WO2020076977A2 (en) | 2018-10-11 | 2020-04-16 | Inhibrx, Inc. | Dll3 single domain antibodies and therapeutic compositions thereof |
| US12077609B2 (en) | 2018-12-21 | 2024-09-03 | Wisconsin Alumni Research Foundation | Variable lymphocyte receptors that target the brain extracellular matrix and methods of use |
| US12371468B2 (en) | 2019-02-11 | 2025-07-29 | Wisconsin Alumni Research Foundation | Variable lymphocyte receptors that target the blood brain barrier and methods of use |
| US20250163144A1 (en) * | 2021-07-27 | 2025-05-22 | Novab, Inc. | Engineered vlrb antibodies with immune effector functions |
| CN114891799B (zh) * | 2022-05-20 | 2024-10-11 | 宁波大学 | 中华绒螯蟹可变淋巴受体vlr2基因及其编码的蛋白和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1118777A (ja) * | 1997-07-09 | 1999-01-26 | Asahi Chem Ind Co Ltd | 新規スリット様ポリペプチド |
| JP2008500064A (ja) | 2004-05-21 | 2008-01-10 | ザ ユーエービー リサーチ ファウンデーション | 可変性リンパ球受容体、その関連ポリペプチドおよび核酸、ならびにその使用 |
| AU2007281284A1 (en) | 2006-08-02 | 2008-02-07 | The Uab Research Foundation | Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity |
| WO2010065407A2 (en) | 2008-12-01 | 2010-06-10 | University Of Maryland Biotechnology Institute | High affinity recombinant sea lamprey antibodies selected by a yeast surface display platform |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| WO2013078425A1 (en) | 2011-11-22 | 2013-05-30 | University Of Maryland, Baltimore | Lambodies with high affinity and selectivity for glycans and uses therefor |
| CN103033617B (zh) * | 2012-11-30 | 2014-12-03 | 辽宁师范大学 | 基于可变淋巴细胞受体的肿瘤标志物检测试剂盒及其制备方法 |
| TWI654206B (zh) | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
| CA2947429A1 (en) | 2014-05-02 | 2015-11-05 | Emory University | Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto |
-
2015
- 2015-04-30 CA CA2947429A patent/CA2947429A1/en not_active Abandoned
- 2015-04-30 US US15/308,535 patent/US10167330B2/en active Active
- 2015-04-30 WO PCT/US2015/028645 patent/WO2015168469A1/en not_active Ceased
- 2015-04-30 JP JP2017510445A patent/JP2017514522A/ja active Pending
- 2015-04-30 KR KR1020167030600A patent/KR20160147787A/ko not_active Ceased
- 2015-04-30 EP EP15786773.0A patent/EP3137496A4/en not_active Withdrawn
- 2015-04-30 CN CN201580021759.0A patent/CN106459173A/zh active Pending
-
2016
- 2016-10-13 IL IL248327A patent/IL248327A0/en unknown
-
2018
- 2018-11-07 US US16/183,340 patent/US20190202887A1/en not_active Abandoned
-
2020
- 2020-04-23 US US16/857,130 patent/US11384134B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017514522A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| JP7094103B2 (ja) | インフルエンザウイルスワクチンおよびその使用 | |
| JP2015096070A5 (enExample) | ||
| JP2017538401A5 (enExample) | ||
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| MX2018010824A (es) | Proteinas de union inducibles y metodos de uso. | |
| JP2021505201A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| HRP20251060T1 (hr) | Samosklapajuće proteinske nanostrukture koje prikazuju f proteine paramiksovirusa i/ili pneumovirusa i njihova uporaba | |
| IL288541B (en) | Vaccine against rsv | |
| JP2018528253A5 (enExample) | ||
| JP2017070289A5 (enExample) | ||
| JP2018528237A5 (enExample) | ||
| JP2018531624A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| JP2008524261A5 (enExample) | ||
| JP2015529678A5 (enExample) | ||
| JP2015514811A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| JP2017524380A5 (ja) | 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法 | |
| JP2016501266A5 (enExample) | ||
| JP2020512284A5 (enExample) | ||
| HK1215441A1 (zh) | 人血清白蛋白结合化合物及其融合蛋白 | |
| JP2017529870A5 (enExample) |